Stent News

Cardiologist defends dissolvable stent after FDA study - WNDU-TV



WNDU-TV
 
Cardiologist defends dissolvable stent after FDA study 
WNDU-TV
But an FDA review showed an 11 percent rate of cardiac problems like heart attack and a 1.9 percent rate of blood clots after two years with the Absorb stent. This compares with 7.9 percent and 0.8 percent with a metal stent. Abbott Laboratories and ...

 


EU docs' panel rejects use of bioresorbable stents - Times of India



Times of India
 
EU docs' panel rejects use of bioresorbable stents 
Times of India
Bioresorbable cardiac stents, which many top cardiologists in India lobbied to keep out of price capping in the name of technological advance, have been ruled out for clinical use by a task force of European cardiologists. They have warned against the ...

 


REVA Medical crosses a milestone by implanting naturally dissolvable stent - Proactive Investors UK



Proactive Investors UK
 
REVA Medical crosses a milestone by implanting naturally dissolvable stent 
Proactive Investors UK
Bioresorbable scaffolds have the potential to offer comparable short-term treatment without the long-term complications of a permanent metallic stent. Fantom is made from Tyrocore, REVA's proprietary tyrosine-derived polymer designed specifically for ...
REVA Announces Commercial Expansion and the First Implant of the Fantom Bioresorbable Scaffold in Switzerland Nasdaq

all 2 news articles » 


Novel strategy of stents in thyroid mass: a case series report of managing severely dyspneic patients - Dove Medical Press



Dove Medical Press
 
Novel strategy of stents in thyroid mass: a case series report of managing severely dyspneic patients 
Dove Medical Press
Background: Tracheal and bronchial stenosis is a life-threatening condition causing difficulty in breathing and even severe respiratory distress. The silicone tracheobronchial stents were placed using the rigid bronchoscopy into the trachea of severe ...

 


Peripheral Stent Industry Global Market Growth, Trends and Insights Analysis Report - Medgadget (blog)



Edition Time (blog)
 
Peripheral Stent Industry Global Market Growth, Trends and Insights Analysis Report 
Medgadget (blog)
Peripheral Stent Market 2017 Industry Research Report has been analyzed in detail to assist clients with all the vital data to frame tactical business judgments and propose strategic growth plans. The Peripheral Stent Market report offers a ...
Global Stent Grafts Market Top Players 2017: Bard, Gore, Medtronic, Terumo, Endologix and Cook Medical Edition Time (blog)
Global EVAR Stent Grafts Market 2017- Medtronic, Boston Scientific, Cardinal Health(Cordis) and Terumo(Vascutek) DailyCommerceNews
Prostate Stent Market Healthcare,Clinical Review,Survey Reports Till 2022 Equity Insider (press release)
Apex News 
all 7 news articles » 


Prices of stent accessories may be capped - Livemint - Livemint



Livemint
 
Prices of stent accessories may be capped - Livemint 
Livemint
An expert panel on coronary stents recommends that the stent accessories be classified as essential drugs, bringing them under price controls.
Stent price capping bad idea, now Centre must fight off this Chinese threat Financial Express
How pharma firms & corporate hospitals fleece patients Daily News & Analysis

all 4 news articles » 


Medtronic Endurant(TM) II/IIs Stent Graft System Receives FDA Approval to Treat Short Neck Anatomies When Used ... - GlobeNewswire (press release)



Medtronic Endurant(TM) II/IIs Stent Graft System Receives FDA Approval to Treat Short Neck Anatomies When Used ... 
GlobeNewswire (press release)
DUBLIN - October 9, 2017 - Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the Endurant(TM) II/IIs stent graft system to treat abdominal aortic aneurysm (AAA) patients with neck ...
Stent graft system approved for treatment of AAA with hostile neck anatomy Healio
FDA Approves Endurant Stent Graft System for AAA Patients MD Magazine

all 3 news articles » 


Government forbids cos from withdrawing stents until December to prevent shortage - Economic Times



Government forbids cos from withdrawing stents until December to prevent shortage 
Economic Times
The department mandated companies to submit a weekly report on coronary stents produced and distributed in the country. They are expected to submit a weekly production plan to the National Pharmaceutical Pricing Authority, the country's drug price ...

and more » 


DCB, newer DES similar in outcomes for coronary in-stent restenosis - Healio



DCB, newer DES similar in outcomes for coronary in-stent restenosis 
Healio
Drug-coated balloons and second-generation drug-eluting stents were equally effective in treating coronary in-stent restenosis, according to a new systematic review and meta-analysis. Although there was no difference between the technologies in all ...

 


Short vs prolonged dual antiplatelet treatment upon endovascular stenting of peripheral arteries - Dove Medical Press



Short vs prolonged dual antiplatelet treatment upon endovascular stenting of peripheral arteries 
Dove Medical Press
Introduction: Peripheral artery disease (PAD) is a highly prevalent disorder with a substantial economical burden. Dual antiplatelet treatment (DAPT) upon endovascular stenting to prevent acute thrombotic reocclusions is an universally accepted ...